Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
20 participants
INTERVENTIONAL
2008-09-30
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Ear Comfort Ear Drops to Treat AOE Cases Compared to DexOtic & Otidin(R)
NCT01584271
Acute Otitis Media: Adjuvant Therapy to Improve Outcome
NCT00000363
Efficacy and Cost Analysis of Steroids in Treatment of Otitis Media With Effusion
NCT03590912
Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa
NCT01359098
The Efficacy of Nasal Steroids in Treatment of Otitis Media With Effusion: Acomparative Study
NCT03491098
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
voltaren ophta
diclofenac sodium
topical solution used in ear 5 drops 8 3/day
2
dexotic
dexotc
aural drops
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
diclofenac sodium
topical solution used in ear 5 drops 8 3/day
dexotc
aural drops
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Children
* Pregnant women
* Immune compromise
* Starting other treatment
* Moderate to severe otitis externa
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sieff Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
victor kizhner
Victor Kizhner MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
victor kizhner, m.d.
Role: PRINCIPAL_INVESTIGATOR
Sieff Medical Center, Safed, ISRAEL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sieff Medical Center
Safed, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Sieff Medical Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP 7-264S
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.